UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000036232
Receipt number R000040615
Scientific Title A clinical study for validity and provision method of periodontal tissue regeneration with autologous adipose derived stem cells and platelet rich plasma
Date of disclosure of the study information 2019/03/17
Last modified on 2019/03/19 09:15:53

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A clinical study for validity and provision method of periodontal tissue regeneration with autologous adipose
derived stem cells and platelet rich plasma

Acronym

Periodontal tissue regeneration using adipose derived stem cells and platelet rich plasma

Scientific Title

A clinical study for validity and provision method of periodontal tissue regeneration with autologous adipose
derived stem cells and platelet rich plasma

Scientific Title:Acronym

Periodontal tissue regeneration using adipose derived stem cells and platelet rich plasma

Region

Japan


Condition

Condition

periodontitis

Classification by specialty

Dental medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the safety and efficacy of transplantation of the mixture of autologous adipose-derived stem cells and platelet-rich plasma for periodontal tissue regeneration

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Validity and efficacy

Key secondary outcomes

Safety


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Transplantation of the processed cells

Interventions/Control_2

Administration of Enamel matrix derivative

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

A patient MUST:
1)Have a Periodontal pocket more than 5 mm at baseline examination.
2) Intrabony defect is 5 mm and more depth, and 2 mm and more width at interproximal site of the experimental tooth by X-ray examination.
3)Already have received initial preparation at the screening.
4)Mobility of experimental tooth is 0, 1, or 2, and exist keratinized gingiva.
5)Good oral health.
6)Subcutaneous fat tissue can be harvest normally and safely
7)20 years and older.
8)Signed informed consent.

Key exclusion criteria

Patient MUST NOT:
1)Can not be measured clinical attachment level of experimental tooth.
2)Have a history of Complicate malignant tumor.
3)Suspected of oral malignant tumor or precancerous lesion.
4)Have a history of usage bisphosphonate, or necessary.
5)Need to undergo the treatment, such as surgical treatment, restorative treatment or root canal treatment, at the experimental tooth within 36 weeks after transplant.
6)Pregnancy, during breastfeeding, or possibility of pregnancy.
7)Have disease of kidney, liver and/or blood.
8)Hemoglobin A1c is more than 6.8% at the screening.
9)Have active infectious diseases.
10)Alcoholism or Drug dependence.
11)Mental or consciousness disorder.
12)HCV antibody, HBs antigen, ATLA virus antibody or HIV antibody positive person.
13)Smoke more than 10 pieces per day.
14)Other,the investigator believes makes him/her unsuitable for participation in the clinical study.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Morikuni
Middle name
Last name Tobita

Organization

Juntendo University Hospital

Division name

Department of Oral and Maxillofacial Surgery

Zip code

113-8431

Address

3-1-3, Hongo, Bunkyo-ku, Tokyo, 113-8431, Japan

TEL

03-3813-3111

Email

mtobita@juntendo.ac.jp


Public contact

Name of contact person

1st name Morikuni
Middle name
Last name Tobita

Organization

Juntendo University Hospital

Division name

Department of Oral and Maxillofacial Surgery

Zip code

113-8431

Address

3-1-3, Hongo, Bunkyo-ku, Tokyo, 113-8431, Japan

TEL

03-3813-3111

Homepage URL


Email

mtobita@juntendo.ac.jp


Sponsor or person

Institute

Juntendo University

Institute

Department

Personal name



Funding Source

Organization

Japan agency of medical research and development

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor

Juntendo clinical research and trial ceter, Juntendo hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical Review Board of Juntendo University Faculty of Medicine

Address

2-1-1,Hongo,Bunkyo-ku,Tokyo

Tel

03-3813-3111

Email

rinri@juntendo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

順天堂大学医学部附属順天堂医院、日本大学松戸歯学部付属病院、愛知学院大学歯学部附属病院


Other administrative information

Date of disclosure of the study information

2019 Year 03 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2019 Year 03 Month 11 Day

Date of IRB

2019 Year 03 Month 18 Day

Anticipated trial start date

2019 Year 03 Month 18 Day

Last follow-up date

2021 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 03 Month 17 Day

Last modified on

2019 Year 03 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040615


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name